EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Predictive Value of Composite Inflammatory Markers for Stroke Prognosis: A Prospective Cohort Study

Bing Wu iD, Jie-Jie Li, Jing Jing iD, Jin-Xi Lin, Xia Meng, Yong Jiang iD, Yong-Jun Wang, Hong-Qiu Gu iD

Annals of Clinical and Translational Neurology · 11.07.2026

DOI: 10.1002/acn3.70473 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Annals of Clinical and Translational Neurology, online erschienen am 11.07.2026. Verfasst von Bing Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Beijing Municipal Science and Technology Commission, the Beijing Hospitals Authority Clinical Medicine Development Special Funding Support, the Beijing Hospitals Authority Qingmiao Talent Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Novel composite inflammatory markers' role in stroke prognosis is understudied, and the best predictor is unclear, requiring further exploration.

Objectives

This study aimed to systematically evaluate the associations of 6 novel composite inflammatory markers on stroke prognosis.

Methods

Based on the Third China National Stroke Registry (CNSR‐III), we analyzed 14,476 participants aged ≥ 18 years with ischemic stroke or transient ischemic attack. Novel composite inflammatory markers were calculated, including neutrophil‐to‐lymphocyte ratio (NLR), platelet‐to‐lymphocyte ratio (PLR), monocyte‐to‐lymphocyte ratio (MLR), systemic immune‐inflammation index (SII), systemic inflammatory response index (SIRI), and pan‐immune inflammation value (PIV). Outcomes at 1 year included stroke recurrence (primary outcome) and ischemic stroke, composite vascular events, mortality, and poor functional outcome (mRS 2–6) as secondary outcomes. Multivariable Cox or logistic regression analyses were performed to estimate the association of composite inflammatory markers with these outcomes. XGBoost, IDI, and NRI were utilized to evaluate predictive performance. Additionally, subgroup analyses and sensitivity tests were conducted to assess the robustness of the findings.

Results

There were 1403 (9.7%), 1300 (9.0%), 1484 (10.3), 483 (3.3%) and 2865 (21.7%) patients with recurrent stroke, ischemic stroke, composite vascular events, mortality, and poor functional outcome within 1 year. SII, PIV, PLR, NLR, SIRI, and MLR were positively associated with stroke recurrence, with hazard ratios (95% CIs) of highest‐quartile vs. lowest‐quartile 1.39 (1.20, 1.61), 1.40 (1.21, 1.62), 1.16 (1.00, 1.34), 1.42 (1.22, 1.66), 1.38 (1.18, 1.61) and 1.18 (1.02, 1.37), respectively. A graded increase in stroke risk across quartiles was observed (Log‐rank p < 0.05). All six markers were positively associated with ischemic stroke, composite vascular events, mortality, and poor functional outcome. SIRI demonstrated better predictive performance [IDI: 0.004 (0.002, 0.007); NRI: 0.082 (0.052, 0.107)] than the other five composite inflammatory markers for stroke recurrence. Among eight XGBoost models, the AUC increased from 0.598 (base) to 0.610 (adding NIHSS/mRS), and further to 0.624 with the addition of SIRI, which was the highest.

Conclusions

Novel composite inflammatory markers were significantly associated with an increased risk of adverse outcomes in stroke patients. When accounting for the influence of inflammatory markers, SIRI demonstrated stronger predictive ability for stroke recurrence than the other markers.

Schlagwörter

Stichwörter der Autor:innen

novel composite inflammatory markerspan‐immune inflammation valueprospective cohort studystroke prognosissystemic inflammatory response index

Autor:innen und Institutionen

  • China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.

ORCID-Profile: Bing Wu, Jing Jing, Yong Jiang, Hong-Qiu Gu

Förderung

  • Beijing Municipal Science and Technology Commission
  • the Beijing Hospitals Authority Clinical Medicine Development Special Funding Support
  • the Beijing Hospitals Authority Qingmiao Talent Program
  • Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park

Zitieren

APA

Wu, B., Li, J. J., Jing, J., Lin, J. X., Meng, X., Jiang, Y., Wang, Y. J., & Gu, H. Q. (2026). Predictive Value of Composite Inflammatory Markers for Stroke Prognosis: A Prospective Cohort Study. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.70473

Vancouver

Wu B, Li JJ, Jing J, Lin JX, Meng X, Jiang Y, et al. Predictive Value of Composite Inflammatory Markers for Stroke Prognosis: A Prospective Cohort Study. Annals of Clinical and Translational Neurology. 2026. doi:10.1002/acn3.70473

BibTeX
@article{Wu2026,
  author = {Wu, Bing and Li, Jie-Jie and Jing, Jing and Lin, Jin-Xi and Meng, Xia and Jiang, Yong and Wang, Yong-Jun and Gu, Hong-Qiu},
  title = {Predictive Value of Composite Inflammatory Markers for Stroke Prognosis: A Prospective Cohort Study},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2026},
  doi = {10.1002/acn3.70473}
}
Kostenlos starten →